Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatmentTorsten Schröder, Jürgen Büning, Vera Olsen et al.|European Journal of Gastroenterology & Hepatology|2015Cited by 36